Abstract:Specimen differences, tissue-dependent background fluorescence and scattering, and deviated specimen position and sensor concentration make optical imaging for labile copper fluctuation in animals questionable, and a signal comparison between specimens is infeasible. We proposed ratiometric optical imaging as an alternative to overcome these disadvantages, and a near-infrared (NIR) ratiometric sensor, BDPS1, was devised therefore by conjugating boron dipyrromethene (BODIPY) with 4-aminostyrene and modifying the 4-amino group as a Cu+ chelator. BDPS1 possessed an excitation ratiometric copper-sensing ability to show the ratio of NIR emission (710 nm) upon excitation at 600 nm to that at 660 nm, Fex600/Fex660, increasing from 2.8 to 10.7. This sensor displayed still the opposite copper response of its internal charge transfer (ICT; 670 nm) and local (581 nm) emission bands. Ratiometric imaging with this sensor disclosed a higher labile copper region near the nucleus apparatus, and HEK-293T cells were more sensitive to copper incubation than MCF-7 cells. Dual excitation ratiometric imaging with this sensor realized tracking of labile copper fluctuation in mice, and the whole-body imaging found that tail intravenous injection of CUTX-101, a therapeutical agent for Menkes disease, led to a distinct labile copper increase in the upper belly. The ex vivo imaging of the resected viscera of mice revealed that CUTX-101 injection enhanced the labile copper level in the liver, intestine, lung, and gall bladder in sequence, yet the kidney, heart, and spleen showed almost no response. This study indicated that modifying BODIPY as an extended ICT fluorophore, with its electron-donating group being derived as a metal chelator, is an effective design rationale of NIR ratiometric sensors for copper tracking in vivo/ex vivo.

NIR Fluorescent Probe with Variable Lipophilicity for Imaging Lysosomal Copper During Cuproptosis in HCC Cells

A lysosomal-targeted fluorescent probe for detecting Cu 2+

Mitochondria-targeted near-infrared fluorescent probe for monitoring of a Copper(I) in living cells and In vivo

A lysosome-targeted near-infrared fluorescent probe for cell imaging of Cu2+

Novel Strategy for Validating the Existence and Mechanism of the "gut-liver axis" in Vivo by a Hypoxia-Sensitive NIR Fluorescent Probe.

A near-infrared turn-on fluorescent sensor for the determination of copper in mitochondria

Near‐infrared Activatable Copper Nanoplatforms Synergize with the 5‐Azacytidine Prodrug to Potentiate Cuproptosis

Targeted copper supplementation oriented theranostic for fluorescence and 19F NMR detection of tumors

Cuproptosis accompanied by obvious •OH generation revealed with an ultrasensitive NIR fluorescence probe

Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis

A 1,8-naphthalimide-based turn-on fluorescent probe for imaging Cu2+ in lysosomes

A lysosome-targeting rhodamine fluorescent probe for Cu2+ detection and its applications in test kits and zebrafish imaging

Construction of a Cu2+-Responsive NIR Fluorescent Probe and the Preliminary Evaluation of its Multifunctional Application

A stable NIR fluorescent probe for imaging lipid droplets in triple-negative breast cancer

Tracking Labile Copper Fluctuation in Vivo/Ex Vivo: Design and Application of a Ratiometric Near-Infrared Fluorophore Derived from 4-Aminostyrene-conjugated Boron Dipyrromethene.

D-A-D type based NIR fluorescence probe for monitoring the cysteine levels in pancreatic cancer cell during ferroptosis

Lysosome-targeted fluorescence probe for discriminating cysteine from homocysteine/glutathione and assessing autophagy in drug-induced liver injury

A near-infrared hepatocyte-targeting probe based on Tricyanofuran to detect cysteine in vivo: Design, synthesis and evaluation

Ketocyanine‐Based Fluorescent Probe Revealing the Polarity Heterogeneity of Lipid Droplets and Enabling Accurate Diagnosis of Hepatocellular Carcinoma

Tumor-Targeting Probe for Dual-Modal Imaging of Cysteine In Vivo

Fucoidan-Copper Nanoparticles to Potentiate Synergistic Cancer Cell Cuproptosis and Immunotherapy